{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:50:11Z","timestamp":1758477011905},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/crd.0000000000000099","type":"journal-article","created":{"date-parts":[[2016,1,24]],"date-time":"2016-01-24T11:26:28Z","timestamp":1453634788000},"page":"248-255","source":"Crossref","is-referenced-by-count":2,"title":["The Subcutaneous Implantable Cardioverter Defibrillator"],"prefix":"10.1097","volume":"24","author":[{"given":"Daniel","family":"Mangels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.CIR.0000136993.34344.41","article-title":"Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study.","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejheart.2004.04.014","article-title":"Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure.","volume":"6","author":"Cleland","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jacc.2010.09.064","article-title":"Systematic review of the incidence of sudden cardiac death in the United States.","volume":"57","author":"Kong","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2014.02.014","article-title":"Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.","volume":"173","author":"Peck","year":"2014","journal-title":"Int J Cardiol"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/CIRCULATIONAHA.112.000547","article-title":"Current evidence base for use of the implantable cardioverter-defibrillator.","volume":"128","author":"Hohnloser","year":"2013","journal-title":"Circulation"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/01.CIR.92.1.59","article-title":"Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.","volume":"92","author":"Zipes","year":"1995","journal-title":"Circulation"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1540-8159.1993.tb01562.x","article-title":"Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions.","volume":"16","author":"Saksena","year":"1993","journal-title":"Pacing Clin Electrophysiol"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/j.1540-8159.1995.tb03867.x","article-title":"Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems.","volume":"18","author":"Korte","year":"1995","journal-title":"Pacing Clin Electrophysiol"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.","volume":"64","author":"Kusumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1540-8159.1999.tb00334.x","article-title":"Complications of third-generation implantable cardioverter defibrillator therapy.","volume":"22","author":"Grimm","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1540-8159.2005.00195.x","article-title":"Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.","volume":"28","author":"Alter","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2007.01.072","article-title":"Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.","volume":"49","author":"Sohail","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0735-1097(02)02620-7","article-title":"Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications.","volume":"41","author":"Ellenbogen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator.","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/europace\/eut016","article-title":"United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn.","volume":"15","author":"Jarman","year":"2013","journal-title":"Europace"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1540-8167.2012.02432.x","article-title":"Feasibility of defibrillation and automatic arrhythmia detection using an exclusively subcutaneous defibrillator system in canines.","volume":"24","author":"Cappato","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00392-011-0303-6","article-title":"Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.","volume":"100","author":"Dabiri Abkenari","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCEP.112.973339","article-title":"Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.","volume":"5","author":"Aydin","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.repc.2014.01.018","article-title":"Subcutaneous implantable cardioverter-defibrillator: Initial experience.","volume":"33","author":"Galv\u00e3o","year":"2014","journal-title":"Rev Port Cardiol"},{"key":"R25-7-20210203","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/eurheartj\/ehs017","article-title":"Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution.","volume":"33","author":"Jarman","year":"2012","journal-title":"Eur Heart J"},{"key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R27-7-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2007.02.087","article-title":"Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators.","volume":"100","author":"Gold","year":"2007","journal-title":"Am J Cardiol"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"R29-7-20210203","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"R30-7-20210203","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming.","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"R31-7-20210203","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCEP.114.001623","article-title":"Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).","volume":"7","author":"Ruwald","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R32-7-20210203","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2012.05.007","article-title":"The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation.","volume":"164","author":"Healey","year":"2012","journal-title":"Am Heart J"},{"key":"R33-7-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study.","volume":"23","author":"Gold","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R34-7-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","article-title":"Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.","volume":"10","author":"K\u00f6be","year":"2013","journal-title":"Heart Rhythm"},{"key":"R35-7-20210203","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2012.05.014","article-title":"Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.","volume":"60","author":"Brignole","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R36-7-20210203","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","article-title":"Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.","volume":"51","author":"Daubert","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R37-7-20210203","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","article-title":"Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.","volume":"57","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R38-7-20210203","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.jacc.2008.01.033","article-title":"Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.","volume":"51","author":"Berul","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R39-7-20210203","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hrthm.2013.12.007","article-title":"Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.","volume":"11","author":"Kooiman","year":"2014","journal-title":"Heart Rhythm"},{"key":"R40-7-20210203","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","article-title":"Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.","volume":"110","author":"Wathen","year":"2004","journal-title":"Circulation"},{"key":"R41-7-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1540-8159.1993.tb01555.x","article-title":"The antitachycardia pacing ICD: impact on patient selection and outcome.","volume":"16","author":"Gross","year":"1993","journal-title":"Pacing Clin Electrophysiol"},{"key":"R42-7-20210203","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacc.2014.01.018","article-title":"The subcutaneous defibrillator: a review of the literature.","volume":"63","author":"Aziz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R43-7-20210203","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/CIRCULATIONAHA.113.006645","article-title":"Subcutaneous implantable cardioverter-defibrillator.","volume":"129","author":"Chang","year":"2014","journal-title":"Circulation"},{"key":"R44-7-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCEP.111.964676","article-title":"Subcutaneous implantable cardioverter defibrillator.","volume":"5","author":"Rowley","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R48-7-20210203","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"key":"R49-7-20210203","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1540-8159.2004.00639.x","article-title":"Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads.","volume":"27","author":"Kettering","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"R50-7-20210203","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ijcard.2014.09.119","article-title":"Pocket infection as a complication of a subcutaneous implantable cardioverter-defibrillator.","volume":"177","author":"Calvagna","year":"2014","journal-title":"Int J Cardiol"},{"key":"R51-7-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF03086226","article-title":"Infection after ICD implantation: operating room versus cardiac catheterisation laboratory.","volume":"17","author":"Remmelts","year":"2009","journal-title":"Neth Heart J"},{"key":"R52-7-20210203","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.","volume":"58","author":"Greenspon","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R53-7-20210203","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/pace.12173","article-title":"Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.","volume":"36","author":"Killingsworth","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"R54-7-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0972-6292(16)30818-X","article-title":"Shoulder joint dislocation as an unusual complication of defibrillation threshold testing following subcutaneous implantable cardioverter-defibrillator implantation.","volume":"14","author":"Noheria","year":"2014","journal-title":"Indian Pacing Electrophysiol J"},{"key":"R55-7-20210203","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/clinchem\/47.3.459","article-title":"Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage.","volume":"47","author":"Schl\u00fcter","year":"2001","journal-title":"Clin Chem"},{"key":"R56-7-20210203","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jce.12705","article-title":"Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis.","volume":"26","author":"El-Chami","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R57-7-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ajkd.2015.01.028","article-title":"Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections.","volume":"66","author":"Dhamija","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R58-7-20210203","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mhj.2001.114195","article-title":"Prevalence of central venous occlusion in patients with chronic defibrillator leads.","volume":"141","author":"Sticherling","year":"2001","journal-title":"Am Heart J"},{"key":"R59-7-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.39.4.495","article-title":"Autopsy findings with permanent pervenous pacemakers.","volume":"39","author":"Robboy","year":"1969","journal-title":"Circulation"},{"key":"R60-7-20210203","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1540-8167.2003.02500.x","article-title":"Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management.","volume":"14","author":"Cooper","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R61-7-20210203","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9149(98)00834-0","article-title":"Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults.","volume":"83","author":"Link","year":"1999","journal-title":"Am J Cardiol"},{"key":"R62-7-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00246-010-9866-7","article-title":"Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease.","volume":"32","author":"Von Bergen","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"R63-7-20210203","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","article-title":"Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.","volume":"11","author":"Groh","year":"2014","journal-title":"Heart Rhythm"},{"key":"R64-7-20210203","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/jce.12343","article-title":"Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening.","volume":"25","author":"Olde Nordkamp","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R65-7-20210203","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/eut370","article-title":"How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?","volume":"16","author":"Randles","year":"2014","journal-title":"Europace"},{"key":"R66-7-20210203","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","article-title":"Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.","volume":"56","author":"Chung","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R67-7-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1540-8159.2009.02590.x","article-title":"Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).","volume":"33","author":"Klein","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"R68-7-20210203","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2013.05.086","article-title":"Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.","volume":"62","author":"Epstein","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R69-7-20210203","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T23:14:38Z","timestamp":1718320478000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201609000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000099","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}